Home
>
National Drug Code (NDC)
>
Kynamro
Kynamro - 58468-0191-2 - (MIPOMERSEN SODIUM)
Drug Information of Kynamro
| Product NDC: | 58468-0191 |
| Proprietary Name: | Kynamro |
| Non Proprietary Name: | MIPOMERSEN SODIUM |
| Active Ingredient(s): | 200 mg/mL & nbsp; MIPOMERSEN SODIUM |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Kynamro
| Product NDC: | 58468-0191 |
| Labeler Name: | Genzyme Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203568 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130129 |
Package Information of Kynamro
| Package NDC: | 58468-0191-2 |
| Package Description: | 4 SYRINGE in 1 CARTON (58468-0191-2) > 1 mL in 1 SYRINGE |
NDC Information of Kynamro
| NDC Code | 58468-0191-2 |
| Proprietary Name | Kynamro |
| Package Description | 4 SYRINGE in 1 CARTON (58468-0191-2) > 1 mL in 1 SYRINGE |
| Product NDC | 58468-0191 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MIPOMERSEN SODIUM |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20130129 |
| Marketing Category Name | NDA |
| Labeler Name | Genzyme Corporation |
| Substance Name | MIPOMERSEN SODIUM |
| Strength Number | 200 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
